Works matching AU Kim, Chong Hwa


Results: 32
    1
    2

    Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study ( TROICA study)

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 635, doi. 10.1111/dom.12866
    By:
    • Ahn, Chang Ho;
    • Han, Kyung Ah;
    • Yu, Jae Myung;
    • Nam, Joo Young;
    • Ahn, Kyu Jeung;
    • Oh, Tae Keun;
    • Lee, Hyoung Woo;
    • Lee, Dae Ho;
    • Kim, Jaetaek;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Kim, Byung Joon;
    • Park, Seok Won;
    • Park, Hyeong Kyu;
    • Lee, Kwang Jae;
    • Kim, Sang‐Wook;
    • Park, Jeong Hyun;
    • Ko, Kwan Pyo;
    • Kim, Chong Hwa;
    • Lee, Hyunjin
    Publication type:
    Article
    3
    4
    5

    Current Long-Term Pharmacotherapies for the Management of Obesity.

    Published in:
    Journal of Obesity & Metabolic Syndrome, 2020, v. 29, n. 2, p. 99, doi. 10.7570/jomes20010
    By:
    • Bo-Yeon Kim;
    • Seon Mee Kang;
    • Jee-Hyun Kang;
    • Kyoung Kon Kim;
    • Bomtaeck Kim;
    • Seung Jun Kim;
    • Yang-Hyun Kim;
    • Jung-Hwan Kim;
    • Jae Hyun Kim;
    • Ga Eun Nam;
    • Ji Yeon Park;
    • Jang Won Son;
    • Hye-Jung Shin;
    • Tae Jung Oh;
    • Hyug Lee;
    • Eon-Ju Jeon;
    • Sochung Chung;
    • Yong Hee Hong;
    • Chong Hwa Kim
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 2, p. 279, doi. 10.4093/dmj.2023.0225
    By:
    • Ye Seul Yang;
    • Nam Hoon Kim;
    • Jong Ha Baek;
    • Seung-Hyun Ko;
    • Jang Won Son;
    • Seung-Hwan Lee;
    • Sang Youl Rhee;
    • Soo-Kyung Kim;
    • Tae Seo Sohn;
    • Ji Eun Jun;
    • In-Kyung Jeong;
    • Chong Hwa Kim;
    • Keeho Song;
    • Eun-Jung Rhee;
    • Junghyun Noh;
    • Kyu Yeon Hur
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

    Published in:
    Endocrinology & Metabolism, 2024, v. 39, n. 5, p. 722, doi. 10.3803/EnM.2024.1995
    By:
    • Nam Hoon Kim;
    • Juneyoung Lee;
    • Suk Chon;
    • Jae Myung Yu;
    • In-Kyung Jeong;
    • Soo Lim;
    • Won Jun Kim;
    • Keeho Song;
    • Ho Chan Cho;
    • Hea Min Yu;
    • Kyoung-Ah Kim;
    • Sang Soo Kim;
    • Soon Hee Lee;
    • Chong Hwa Kim;
    • Soo Heon Kwak;
    • Yong‐ho Lee;
    • Choon Hee Chung;
    • Sihoon Lee;
    • Heung Yong Jin;
    • Jae Hyuk Lee
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32